 Deutsche Bank AG trimmed its holdings in shares of Enzo Biochem, Inc. NYSE:ENZ by 35.6 in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 13,731 shares of the medical research companys stock after selling 7,598 shares during the period. Deutsche Bank AGs holdings in Enzo Biochem were worth ... 